Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Dipeptidyl Peptidase IV (DPP-IV) Inhibitorsmarket, defines the market attractiveness level of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors industry, describes the types of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market and the development prospects and opportunities of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market in Chapter 13.
By Player:
Eli Lilly
Mitsubishi Tanabe Pharma
AstraZeneca
Novartis
Takeda
Boehringer
Merck
By Type:
Sitagliptin
Vildagliptin
Saxagliptin
Linagliptin
Others
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
-
7.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
-
7.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
-
7.4 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
-
7.5 Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
-
7.6 India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
-
7.7 South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption (2017-2022)
8 Region and Country-wise Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
-
8.4 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
-
8.6 India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast (2022-2028)
9 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Sitagliptin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Vildagliptin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Saxagliptin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Linagliptin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Sitagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Vildagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Saxagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Linagliptin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
14.2 Mitsubishi Tanabe Pharma
-
14.2.1 Mitsubishi Tanabe Pharma Company Details
-
14.2.2 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
14.3 AstraZeneca
-
14.3.1 AstraZeneca Company Details
-
14.3.2 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
14.4 Novartis
-
14.4.1 Novartis Company Details
-
14.4.2 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
14.5 Takeda
-
14.5.1 Takeda Company Details
-
14.5.2 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
14.6 Boehringer
-
14.6.1 Boehringer Company Details
-
14.6.2 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors
-
Figure Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Picture
-
Table Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption by Country (2017-2022)
-
Figure United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sitagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Vildagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Saxagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Linagliptin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Sitagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vildagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Saxagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Linagliptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
Table Mitsubishi Tanabe Pharma (Foundation Year, Company Profile and etc.)
-
Table Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
Table Boehringer (Foundation Year, Company Profile and etc.)
-
Table Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product and Service
-
